|
Age (years)
|
64 ± 14
|
64 ± 15
|
66 ± 12
|
0.15
|
|
Men, n (%)
|
261 (57)
|
182 (54)
|
79 (65)
|
0.04
|
|
Body mass index (kg/m2)
|
23 ± 4
|
23 ± 3
|
25 ± 4
|
<0.01
|
|
Waist circumference (cm)
|
84 ± 11
|
82 ± 10
|
88 ± 11
|
<0.01
|
|
Subcutaneous adipose tissue (cm2)
|
136 ± 79
|
132 ± 76
|
147 ± 84
|
0.08
|
|
Visceral adipose tissue (cm2)
|
95 ± 55
|
88 ± 52
|
116 ± 58
|
<0.01
|
|
Hypertension, n (%)
|
263 (58)
|
176 (53)
|
87 (71)
|
<0.01
|
|
Dyslipidemia, n (%)
|
208 (46)
|
130 (39)
|
78 (66)
|
<0.01
|
|
Current smoking, n (%)
|
98 (21)
|
72 (22)
|
26 (21)
|
0.96
|
|
Total cholesterol (mg/dl)
|
187 ± 37
|
188 ± 38
|
187 ± 36
|
0.95
|
|
Triglycerides (mg/dl)
|
143 (88)
|
138 (107)
|
154 (121)
|
0.02
|
|
HDL-cholesterol (mg/dl)
|
57 ± 16
|
58 ± 16
|
56 ± 17
|
0.16
|
|
LDL-cholesterol (mg/dl)
|
111 ± 32
|
111 ± 33
|
110 ± 30
|
0.93
|
|
Hemoglobin A1c (%)
|
6.2 ± 1.2
|
5.7 ± 0.4
|
7.4 ± 1.6
|
<0.01
|
|
High sensitivity CRP (mg/dl)
|
0.16 (0.08)
|
0.15 (0.08)
|
0.17 (0.09)
|
0.30
|
|
Medications
| | | | |
|
Antihypertensive agents, n (%)
|
239 (52)
|
160 (48)
|
79 (65)
|
<0.01
|
|
Lipid lowering agents n (%)
|
138 (30)
|
84 (25)
|
54 (44)
|
<0.01
|
|
Hypoglycemic agents, n (%)
|
82 (18)
|
0 (0)
|
82 (67)
|
<0.01
|
